SNN
Smith & Nephew SNATS IncNYSEHEALTHCAREMEDICAL DEVICES
Key Statistics
Market Cap
$14.10B
P/E Ratio
23.10
EPS
$1.43
Beta
0.74
52W High
$37.90
52W Low
$24.78
50-Day MA
$34.17
200-Day MA
$34.05
Dividend Yield
2.46%
Profit Margin
10.10%
Forward P/E
12.47
PEG Ratio
0.66
About Smith & Nephew SNATS Inc
Smith & Nephew plc develops, manufactures, markets and sells medical devices worldwide. The company is headquartered in Watford, the United Kingdom.
Fundamentals
| Revenue (TTM) | $6.16B |
| Gross Profit (TTM) | $4.21B |
| EBITDA | $1.34B |
| Operating Margin | 14.00% |
| Return on Equity | 11.80% |
| Return on Assets | 5.27% |
| Revenue/Share (TTM) | $2.84 |
| Book Value | $6.22 |
| Price-to-Book | 2.59 |
| Price-to-Sales (TTM) | 2.29 |
| EV/Revenue | 2.674 |
| EV/EBITDA | 10.76 |
| Quarterly Earnings Growth (YoY) | 70.40% |
| Quarterly Revenue Growth (YoY) | 7.40% |
| Shares Outstanding | $426.79M |
| Float | $843.42M |
| % Insiders | 0.01% |
| % Institutions | 7.63% |
Historical Volatility
HV 10-Day
27.58%
HV 20-Day
22.59%
HV 30-Day
27.59%
HV 60-Day
26.58%
HV Rank
64.3%
Volatility is currently contracting
Analyst Ratings
Consensus ($36.62 target)
1
Buy4
HoldData last updated: 4/9/2026